Clinical Trial

Investigation of Locus Coeruleus Function in Sustained Attention

Study acronym: LC
Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The norepinephrine-producing locus coeruleus (LC) is thought to be central to a wide array of cognitive functions, like attention and goal pursuit, and has been implicated in dysfunctions including attention deficit hyperactivity disorder and schizophrenia. The goal of this proposal is to develop methods that permit measurement of activity in the human LC. Because the LC is small and located in the pons, the Investigators will use high resolution magnetic resonance imaging techniques tailored to the brainstem environment, including neuromelanin-sensitive images shown to delineate the LC, combined with pharmacological manipulation to confirm the location of functional activity.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2023-09-10; most recent amendment 2026-06-16.
Trial Details
NCT Number NCT06041048
Lead Sponsor University of California, Davis
Conditions Attention - no Condition is Being Assessed - Healthy Adults
Enrollment 40 participants
Start Date 2023-10-01
Primary Completion 2026-12-19 (estimated)
Study Completion 2026-12-19 (estimated)
Updated on ClinicalTrials.gov 2026-06-18